|
1
|
Cervantes A, Roda D, Tarazona N, Roselló S
and Pérez-Fidalgo JA: Current questions for the treatment of
advanced gastric cancer. Cancer Treat Rev. 39:60–67. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schaefer U, Voloshanenko O, Willen D and
Walczak H: TRAIL: a multifunctional cytokine. Front Biosci.
12:3813–3824. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morizot A, Mérino D, Lalaoui N, et al:
Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the
DISC level. Cell Death Differ. 18:700–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu L, Qu X, Luo Y, et al: Epirubicin
enhances TRAIL-induced apoptosis in gastric cancer cells by
promoting death receptor clustering in lipid rafts. Mol Med Rep.
4:407–411. 2011.
|
|
5
|
Cho IR, Koh SS, Min HJ, et al: Reovirus
infection induces apoptosis of TRAIL-resistant gastric cancer cells
by down-regulation of Akt activation. Int J Oncol. 36:1023–1030.
2010.PubMed/NCBI
|
|
6
|
Van Schaeybroeck S, Kelly DM, Kyula J,
Stokesberry S, Fennell DA, Johnston PG and Longley DB: Src and
ADAM-17-mediated shedding of transforming growth factor-α is a
mechanism of acute resistance to TRAIL. Cancer Res. 68:8312–8321.
2008.PubMed/NCBI
|
|
7
|
Xu L, Zhang Y, Liu J, et al:
TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in
lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer
cells. Eur J Cancer. 48:3288–3299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang S, Yu S, Shi W, Ge L, Yu X, Fan J and
Zhang J: Curcumin inhibits the migration and invasion of mouse
hepatoma Hca-F cells through down-regulating caveolin-1 expression
and epidermal growth factor receptor signaling. IUBMB Life.
63:775–782. 2011.
|
|
9
|
Zhang B, Peng F, Wu D, Ingram AJ, Gao B
and Krepinsky JC: Caveolin-1 phosphorylation is required for
stretch-induced EGFR and Akt activation in mesangial cells. Cell
Signal. 19:1690–1700. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Kalyankrishna S, Wislez M, et al:
SRC-family kinases are activated in non-small cell lung cancer and
promote the survival of epidermal growth factor receptor-dependent
cell lines. Am J Pathol. 170:366–376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu T, Zhang B, Ye F and Xiao Z: A
potential role for caveolin-1 in VEGF-induced fibronectin
upregulation in mesangial cells: involvement of VEGFR2 and Src. Am
J Physiol Renal Physiol. 304:F820–F830. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Z, Bakhshi FR, Shajahan AN, et al:
Nitric oxide-dependent Src activation and resultant caveolin-1
phosphorylation promote eNOS/caveolin-1 binding and eNOS
inhibition. Mol Biol Cell. 23:1388–1398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Roche O, Xu C, et al: Hypoxia
promotes ligand-independent EGF receptor signaling via
hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc
Natl Acad Sci USA. 109:4892–4897. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu L, Qu X, Zhang Y, et al: Oxaliplatin
enhances TRAIL-induced apoptosis in gastric cancer cells by
CBL-regulated death receptor redistribution in lipid rafts. FEBS
Lett. 583:943–948. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Irwin ME, Mueller KL, Bohin N, Ge Y and
Boerner JL: Lipid raft localization of EGFR alters the response of
cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J
Cell Physiol. 226:2316–2328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dittmann K, Mayer C, Kehlbach R and
Rodemann HP: Radiation-induced caveolin-1 associated EGFR
internalization is linked with nuclear EGFR transport and
activation of DNA-PK. Mol Cancer. 7:692008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sham D, Wesley UV, Hristova M and van der
Vliet A: ATP-mediated transactivation of the epidermal growth
factor receptor in airway epithelial cells involves DUOX1-dependent
oxidation of Src and ADAM17. PLoS One. 8:e543912013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
De Luca A, D’Alessio A, Gallo M, Maiello
MR, Bode AM and Normanno N: Src and CXCR4 are involved in the
invasiveness of breast cancer cells with acquired resistance to
lapatinib. Cell Cycle. 13:148–156. 2014.PubMed/NCBI
|
|
19
|
Samarakoon R, Chitnis SS, Higgins SP,
Higgins CE, Krepinsky JC and Higgins PJ: Redox-induced Src
kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3
activation and PAI-1 expression. PLoS One. 6:e228962011.PubMed/NCBI
|
|
20
|
Dittmann K, Mayer C, Kehlbach R, Rothmund
MC and Peter Rodemann H: Radiation-induced lipid peroxidation
activates src kinase and triggers nuclear EGFR transport. Radiother
Oncol. 92:379–382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gottlieb-Abraham E, Shvartsman DE,
Donaldson JC, Ehrlich M, Gutman O, Martin GS and Henis YI:
Src-mediated caveolin-1 phosphorylation affects the targeting of
active Src to specific membrane sites. Mol Biol Cell. 24:3881–3895.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen J, Chen JK and Harris RC: Angiotensin
II induces epithelial-to-mesenchymal transition in renal epithelial
cells through reactive oxygen species/Src/caveolin-mediated
activation of an epidermal growth factor receptor-extracellular
signal-regulated kinase signaling pathway. Mol Cell Biol.
32:981–991. 2012. View Article : Google Scholar
|
